Floxuridine and Dexamethasone as a Hepatic Arterial Infusion and Bevacizumab in Treating Patients With Primary Liver Cancer That Cannot be Removed by Surgery
PHASE2
RATIONALE: Drugs used in chemotherapy, such as floxuridine and dexamethason...
Status
Completed
Location
New York Weill Cornell Cancer Center at Cornell University
Gemcitabine and Oxaliplatin Chemotherapy With or Without a Floxuridine and Dexamethasone Pump in People With Cholangiocarcinoma That Cannot Be Removed With Surgery
PHASE2
This study will compare the safety and effects of HAI floxuridine and dexam...
Status
Recruiting
Location
National Heart, Lung, and Blood Institute (NIH) (Data Collection Only)
A Phase II Study of Continuous Hepatic Arterial Infusion With Floxuridine (FUDR) and Dexamethasone (DEX) in Patients With Unresectable Primary Hepatic Malignancy
PHASE2
This phase II study aims to evaluate regional chemotherapy in patients with...
Hepatic Arterial Infusion (HAI) With Floxuridine (FUDR) and Dexamethasone (Dex) Combined With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma (ICC)
PHASE2
The purpose of this study is to use both, liver pump treatment and systemic...